History

The Theorem Clinical Research name is relatively new, but it is built on a long history of delivering exceptional services and support for all phases of clinical research. Before its launch in 2011, Theorem operated as a subsidiary of Omnicare Inc., tracing its roots back to 1985.

Today, Theorem is a global organization with 1,000+ employees located throughout more than 30 countries. As our story continues to unfold, one factor remains constant: We remain committed to our clients and their success and strive for excellence at every opportunity. Theorem understands your evolving drug, device and combination clinical studies development needs and pledges to meet them far into the future.

Key Milestones

1985: Omnicare Inc. launches.

2000: Omnicare Inc. establishes Omnicare Clinical Research Inc.

2002: Omnicare Clinical Research opens offices in Bangalore, India, and Tokyo, Japan, to further penetrate Asia-Pacific region.

2003: Omnicare Clinical Research's PAGeR Business Unit is established to provide dedicated resources for conducting peri-approval (Phase IIIb and IV) trials and clinical research projects in seniors.

2004: Omnicare Inc. acquires an additional CRO, Clinimetrics Research Associates Inc., and strengthens medical device trial capabilities.

2005: Omnicare Inc. celebrates 20th anniversary.

2007: Omnicare Clinical Research launches OmnieView University, a state-of-the-art eLearning Management System, providing targeted, online training to internal and external project members.

2008: Client Placement Service is launched, bringing Omnicare Clinical Research professionals on site to client locations for extended assignments, formalized under the OmniTEAM^® brand name.

2009: Omnicare Clinical Research launches Cardiovascular, Oncology and Vaccines Therapeutic Advisory Teams, providing projects with additional support from a medical, operational, regulatory and cost-effective perspective.

2010: Omnicare Clinical Research integrates operations with sister CRO, Clinimetrics Research Associates. This integrative approach results in increased therapeutic reach, an exchange of expertise and expanded global resources, coupled with specialization into focused business units designed to meet the specific needs of clients.

2011: Omnicare Clinical Research and Clinimetrics Research Associates are acquired by Nautic Partners, LLC, a strategic growth private equity firm. As part of the move, Omnicare Clinical Research and Clinimetrics Research Associates become Theorem Clinical Research and begin to re-brand as an independent company focused on delivering expert clinical trial expertise and support at every phase of drug and device development.